K-ras alterations in Danish ovarian tumour patients. From the danish "Malova" Ovarian Cancer Study

Gynecologic Oncology

Volumn 89, Issue 1, 2003, Pages 31-36

  Høgdall, Estrid V S ^a,b   Høgdall, Claus K ^c   Blaakaer, Jan ^d   Christensen, Lise ^c   Bock, Johannes E ^c   Vuust, Jens ^b   Glud, Eva ^a   Kjaer, Susanne K ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Rigshospitalet   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE ACTIVATION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; MULTIVARIATE ANALYSIS; MUTATION RATE; ONCOGENE K RAS; OVARY CANCER; OVARY TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0344406947     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00005-2     Document Type: Article

References (29)

1. Kjaer S., Ewertz M. Ovarian cancer i Denmark 1943-1982 Kraeftstatistik nr. 20 . Ugeskr Laeger. 149:1987;3356-3360.
2. Kjaer SK, Storm HH. Female genital organs. In: survival of Danish Cancer patients 1943-87. Carstensen B, Storm HH, Schou G: APMIS, Munksgaard, Copenhagen, 1993:Suppl. 33, 107-121.
3. Gøtrik JK, Hjulsager M. Cancer incidence in Denmark 1997. 1997:11, -81, Sundhedsstyrrelsen, Copenhagen.
4. Cancer in the Nordic Countries 1999: 1, -19, Association of the Nordic Cancer Registries 1999, Copenhagen.
5. Krag E, Ingerslev O. Cancer incidence in Denmark 1994. 1997:1 -96, Sundhedsstyrelsen, Copenhagen.
6. Levine A.J., Perry M.E., Chang A., Silver A., Dittmer D., Wu M., et al. The 1993 Walter Hubert Lecture the role of the p53 tumour-suppressor gene in tumorigenesis . Br J Cancer. 69:1994;409-416.
7. Weinberg R.A. How cancer arises. Sci Am. 275:1996;32-40.
8. Morita K., Ono Y., Fukui H., Tomita S., Ueda Y., Terano A., et al. Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors. Pathol Int. 50:2000;219-223.
9. Aunoble B., Sanches R., Didier E., Bignon Y.J. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer [review]. Int J Oncol. 16:2000;567-576.
10. Varras M.N., Sourvinos G., Diakomanolis E., Koumantakis E., Flouris G.A., Lekka-Katsouli J., et al. Detection and clinical correlations of ras gene mutations in human ovarian tumors. Oncology (Huntingt). 56:1999;89-96.
11. Enomoto T., Weghorst C.M., Inoue M., Tanizawa O., Rice J.M. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol. 139:1991;777-785.
12. Teneriello M.G., Ebina M., Linnoila R.I., Henry M., Nash J.D., Park R.C., et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108.
13. Ichikawa Y., Nishida M., Suzuki H., Yoshida S., Tsunoda H., Kubo T., et al. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. published erratum appears in Cancer Res 1994 Mar 1;54(5):1391 Cancer Res. 54:1994;33-35.
14. Walsh P.S., Metzger D.A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 10:1991;506-513.
15. Al-Jehani R.M., Jeyarajah A.R., Hagen B., Hogdall E.V., Oram D.H., Jacobs I.J. Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis. J Natl Cancer Inst. 90:1998;540-542.
16. Høgdall E., Boye K., Vuust J. Simple preparation method of PCR fragments for automated DNA sequencing. J Cell Biochem. 73:1999;433-436.
17. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
18. Bos J.L. ras oncogenes in human cancer a review . Cancer Res. 49:1989;4682-4689. published erratum appears in Cancer Res 1990 Feb 15;50(4):1352.
19. Scambia G., Masciullo V., Benedetti Panici P., Marone M., Ferrandina G., Todaro N., et al. Prognostic significance of ras/p21 alterations in human ovarian cancer. Br J Cancer. 75:1997;1547-1553.
20. Chien C.H., Chow S.N. Point mutation of the ras oncogene in human ovarian cancer. DNA Cell Biol. 12:1993;623-627.
21. Pieretti M., Powell D.E., Gallion H.H., Case E.A., Conway P.S., Turker M.S. Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors. Hum Pathol. 26:1995;393-397.
22. Fujita M., Enomoto T., Inoue M., Tanizawa O., Ozaki M., Rice J.M., et al. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Jpn J Cancer Res. 85:1994;1247-1256.
23. Mok S.C., Bell D.A., Knapp R.C., Fishbaugh P.M., Welch W.R., Muto M.G., et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492.
24. Fukumoto M., Estensen R.D., Sha L., Oakley G.J., Twiggs L.B., Adcock L.L., et al. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res. 49:1989;1693-1697.
25. Garrett A.P., Lee K.R., Colitti C.R., Muto M.G., Berkowitz R.S., Mok S.C. k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 20:2001;244-251.
26. Kovalchuk O., Naumnik W., Serwicka A., Chyczewska E., Niklinski J., Chyczewski L. K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report. Folia Histochem Cytobiol. 39:(Suppl 2):2001;70-72.
27. Zambon C., Navaglia F., Basso D., Gallo N., Greco E., Piva M.G., et al. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients an unsatisfactory technique for clinical applications . Clin Chim Acta. 302:2000;35-48.
28. Cuatrecasas M., Erill N., Musulen E., Costa I., Matias-Guiu X., Prat J. K-ras mutations in nonmucinous ovarian epithelial tumors a molecular analysis and clinicopathologic study of 144 patients . Cancer. 82:1998;1088-1095.
29. Cuatrecasas M., Villanueva A., Matias-Guiu X., Prat J. K-ras mutations in mucinous ovarian tumors a clinicopathologic and molecular study of 95 cases . Cancer. 79:1997;1581-1586.